Br J Dermatol. 1999 Sep;141(3):424-9.

Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.

Source

Department of Dermatology, University of Kiel, Schittenhelmstr. 7, 24105 Kiel, Germany. urowietz@dermatology.uni-kiel.de

Abstract

Fumaric acid ester (FAE) therapy has proved to be safe and effective in patients with severe psoriasis vulgaris. This treatment was introduced nearly 30 years ago, but is only now gaining renewed interest among dermatologists. FAE therapy is licensed in Germany and registration is pending in many European countries. Multicentre trials have confirmed the beneficial effect of FAE in psoriasis and have defined the spectrum of its adverse effects. Although the mode of action of FAEs in the treatment of psoriasis is not fully understood, recent experimental data point towards a skewing of the Th1-dominated T-cell response in psoriasis to a Th2-like pattern, and inhibition of proliferation of keratinocytes. This article reviews the experimental and clinical information on FAEs in psoriasis and provides guidelines for the clinical use of FAEs derived from a consensus meeting of leading experts.

PMID:: 10584060; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Psoriasis - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Use of fumaric acid esters in psoriasis. [Indian J Dermatol Venereol Lep...]
Use of fumaric acid esters in psoriasis.
Roll A, Reich K, Boer A. Indian J Dermatol Venereol Leprol. 2007 Mar-Apr; 73(2):133-7.
Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. [Br J Dermatol. 1998]
Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
Mrowietz U, Christophers E, Altmeyer P. Br J Dermatol. 1998 Mar; 138(3):456-60.
Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. [Dermatology. 1998]
Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.
Höxtermann S, Nüchel C, Altmeyer P. Dermatology. 1998; 196(2):223-30.
Review Fumaric acid esters. [Clin Dermatol. 2008]
Review Fumaric acid esters.
Rostami Yazdi M, Mrowietz U. Clin Dermatol. 2008 Sep-Oct; 26(5):522-6.
Review Dimethylfumarate for psoriasis: more than a dietary curiosity. [Trends Mol Med. 2005]
Review Dimethylfumarate for psoriasis: more than a dietary curiosity.
Mrowietz U, Asadullah K. Trends Mol Med. 2005 Jan; 11(1):43-8.

See reviews... See all...

Cited by 10 PubMed Central articles

Review Development of oral immunomodulatory agents in the management of multiple sclerosis. [Drug Des Devel Ther. 2011]
Review Development of oral immunomodulatory agents in the management of multiple sclerosis.
Nicholas R, Giannetti P, Alsanousi A, Friede T, Muraro PA. Drug Des Devel Ther. 2011; 5:255-74. Epub 2011 May 10.
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease. [PLoS One. 2011]
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.
Ellrichmann G, Petrasch-Parwez E, Lee DH, Reick C, Arning L, Saft C, Gold R, Linker RA. PLoS One. 2011 Jan 31; 6(1):e16172. Epub 2011 Jan 31.
New oral disease-modifying therapies for multiple sclerosis. [F1000 Med Rep. 2009]
New oral disease-modifying therapies for multiple sclerosis.
Bagert BA, Bourdette D. F1000 Med Rep. 2009 May 8; 1. Epub 2009 May 8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of severe psoriasis with fumaric acid esters: scientific background an...
Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.
Br J Dermatol. 1999 Sep ;141(3):424-9.

PubMed
Effects of an omnivorous diet compared with a lactoovovegetarian diet on resista...
Effects of an omnivorous diet compared with a lactoovovegetarian diet on resistance-training-induced changes in body composition and skeletal muscle in older men.
Am J Clin Nutr. 1999 Dec ;70(6):1032-9.

PubMed
Dietary saturated fats and their food sources in relation to the risk of coronar...
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women.
Am J Clin Nutr. 1999 Dec ;70(6):1001-8.

PubMed
Setting the standards: quality control in the secretory pathway.
Setting the standards: quality control in the secretory pathway.
Science. 1999 Dec 3 ;286(5446):1882-8.

PubMed
Transgenic expression of green fluorescent protein in mouse oxytocin neurones.
Transgenic expression of green fluorescent protein in mouse oxytocin neurones.
J Neuroendocrinol. 1999 Dec ;11(12):935-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: